Company Overview

We are a clinical stage biopharmaceutical company focused on drug development and delivery in diabetes and other cardiometabolic diseases.

We are applying our proprietary technology platform, Arestat®, to develop a portfolio of proprietary products that address areas of high unmet need in high value markets, as well as working with leading pharmaceutical and biotechnology companies to deliver enhanced therapeutics.

 

Latest documents

Arecor talks to Biotech TV

23 February 2026

Arecor and Sequel Med Tech Fireside Panel Discussion

7 January 2026

Arecor and Sequel Med Tech Fireside Panel Discussion

7 January 2026

Contact: ir@arecor.com